# Peptides for weight loss: what works and what is legal

Source: https://aminodesk.com/goals/weight-loss
Publisher: Amino Desk
Updated: 2026-11-17
Clinical review: pending

Two drugs have FDA approval and large trials behind them for weight loss: semaglutide and tirzepatide. Everything else sold for fat loss is experimental, approved only abroad, or backed by animal data.

**The short version**

- **Approved and proven:** semaglutide (average 14.9% of body weight lost over 68 weeks in its main trial) and tirzepatide (20.9% over 72 weeks at the top dose).
- **In trials, not legally for sale:** retatrutide, cagrilintide and survodutide.
- **Tested and failed:** AOD-9604 showed no significant weight loss against placebo in its 536-person trial.
- **If you start a GLP-1:** part of the weight lost is muscle. See [protein and muscle on GLP-1 medications](https://aminodesk.com/guides/protein-on-glp-1).

## Better studied

Grades describe the evidence for a compound's best-studied use, which is not always the use on this page. The summary under each name says what was actually tested. [How the grades work](https://aminodesk.com/finder).

### [Semaglutide](https://aminodesk.com/library/semaglutide)

Grade A FDA-approved

The most studied weight-loss drug available. Sold as Wegovy and Ozempic, as a weekly injection or a daily pill. Large trials behind it and a known side-effect profile.

### [Tirzepatide](https://aminodesk.com/library/tirzepatide)

Grade A FDA-approved

Acts on two hormone receptors instead of one. Sold as Zepbound and Mounjaro. Produced some of the largest weight reductions seen in obesity trials.

### [Tesamorelin](https://aminodesk.com/library/tesamorelin)

Grade A FDA-approved

The only growth-hormone-type drug with a current FDA approval. Narrowly approved to reduce excess abdominal fat in people with HIV and lipodystrophy; the fat returns if you stop.

### [Retatrutide](https://aminodesk.com/library/retatrutide)

Grade B Investigational

Eli Lilly's experimental triple-hormone injection, with strong Phase 3 results and a planned FDA filing. Available only through clinical trials right now.

### [Mazdutide](https://aminodesk.com/library/mazdutide)

Grade B Not in the US

A weekly weight-loss injection approved in China in 2025. Real approval, real trials, but no route to it in the United States.

### [Cagrilintide (and CagriSema)](https://aminodesk.com/library/cagrilintide)

Grade B Investigational

An amylin drug that, paired with semaglutide as CagriSema, produced about 20% weight loss in a large trial. Under FDA review; the FDA says it cannot be compounded.

### [Survodutide](https://aminodesk.com/library/survodutide)

Grade B Investigational

A weekly GLP-1 and glucagon injection with about 13% average weight loss in a 76-week Phase 3 trial. Not approved; stomach side effects were common.

### [AOD-9604](https://aminodesk.com/library/aod-9604)

Grade B No legal route

Tested properly and failed. Its 536-person trial found no significant weight loss against placebo. Safety record was clean; the drug simply did not work.

### [L-carnitine (injectable)](https://aminodesk.com/library/l-carnitine)

Grade B Mixed

Approved for carnitine deficiency and sold as weight-loss shots. Dozens of trials, mostly oral, show about 1 kg of extra weight loss; the shots themselves are untested.

## Little or no human evidence

### [5-amino-1MQ](https://aminodesk.com/library/5-amino-1mq)

Grade D No legal route

Not a peptide. Blocks an enzyme involved in NAD+ metabolism. Striking results in obese mice, zero published human trials, and a 40-fold spread in the doses people inject.

### [SLU-PP-332](https://aminodesk.com/library/slu-pp-332)

Grade D No legal route

The "exercise pill." Mice ran 70% longer and obese mice lost weight. No human has been given it in a registered trial.

### [Adipotide](https://aminodesk.com/library/adipotide)

Grade D No legal route

Destroys the blood vessels feeding fat tissue. Produced about 11% weight loss in monkeys and damaged the kidneys of every treated animal at the same doses.

### [MOTS-c](https://aminodesk.com/library/mots-c)

Grade D 2026 policy

Encoded in mitochondrial DNA and marketed for metabolism and energy. Newly compoundable, with the human evidence still to come.

## What you can legally get

- **FDA-approved, by prescription:** [Semaglutide](https://aminodesk.com/library/semaglutide), [Tirzepatide](https://aminodesk.com/library/tirzepatide), [Tesamorelin](https://aminodesk.com/library/tesamorelin)
- **Compoundable on prescription under the October 2026 policy:** [MOTS-c](https://aminodesk.com/library/mots-c)
- **Depends on the form (see the page):** [L-carnitine (injectable)](https://aminodesk.com/library/l-carnitine)
- **In clinical trials only:** [Retatrutide](https://aminodesk.com/library/retatrutide), [Cagrilintide (and CagriSema)](https://aminodesk.com/library/cagrilintide), [Survodutide](https://aminodesk.com/library/survodutide)
- **Approved abroad, not available in the US:** [Mazdutide](https://aminodesk.com/library/mazdutide)
- **No legal route in the US:** [AOD-9604](https://aminodesk.com/library/aod-9604), [5-amino-1MQ](https://aminodesk.com/library/5-amino-1mq), [SLU-PP-332](https://aminodesk.com/library/slu-pp-332), [Adipotide](https://aminodesk.com/library/adipotide)

Products sold online as "research use only" are outside every one of these routes. See [how to vet a provider](https://aminodesk.com/providers).

## Keep reading

- [Semaglutide vs tirzepatide](https://aminodesk.com/compare/semaglutide-vs-tirzepatide)
- [What they cost](https://aminodesk.com/costs)
- [Protein and muscle on GLP-1s](https://aminodesk.com/guides/protein-on-glp-1)
- [What "GLP-3" and other seller code names mean](https://aminodesk.com/guides/seller-code-names)
- [Filter all 40 compounds by goal and legal status](https://aminodesk.com/finder)

This page summarizes our compound pages. The sources for every claim are listed on each of those pages.

---
Educational information from Amino Desk (aminodesk.com), not medical advice. Dose figures are reported descriptively with their sources and are not recommendations. Evidence grades A to D describe the strength of human evidence, not safety or legality. When you use this content, cite the page URL.
